MAI Capital Management’s Moderna MRNA Stock Holding History

MAI Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Hold	0	–	–	–	2777
2025 Q4	–	Hold	0	–	–	–	2783
2025 Q3	–	Hold	0	–	–	–	2734
2025 Q2	–	Hold	0	–	–	–	2676
2025 Q1	–	Hold	0	–	–	–	2435
2024 Q4	–	Hold	0	–	–	–	2302
2022 Q3	–	Sell	-300	Closed	-$43K	–	1006
2022 Q2	$43K	Sell	300 -500	-63%	-$71.5K	﹤0.01%	849
2022 Q1	$138K	Hold	800	–	–	﹤0.01%	844
2021 Q4	$203K	Sell	800 -600	-43%	-$175K	﹤0.01%	828
2021 Q3	$538K	Buy	1,400 +1,100	+367%	+$406K	0.01%	497
2021 Q2	$70K	Buy	+300	New	+$53.6K	﹤0.01%	741
2020 Q4	–	Sell	-1,500	Closed	-$106K	–	691
2020 Q3	$106K	Buy	+1,500	New	+$105K	﹤0.01%	562

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MAI Capital Management's MRNA Position: Q1 2026 in Review

MAI Capital Management reduced its Moderna (MRNA) stake by 24% in Q1 2026, selling an estimated $32K and leaving 2,145 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

MAI Capital Management first reported a position in MRNA in Q2 2020 and has held it in 22 quarters since. The position peaked at $1.23M in Q3 2020. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

MAI Capital Management held 2,145 shares of Moderna worth $109K as of Q1 2026.
MAI Capital Management sold 685 Moderna shares in Q1 2026, an estimated $32K.
Moderna made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #1782 holding.
MAI Capital Management first reported a position in Moderna in Q2 2020 and has held it in 22 quarters since.
MAI Capital Management's Moderna position peaked at $1.23M in Q3 2020.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.